{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T10:44:23Z","timestamp":1770720263639,"version":"3.49.0"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2011,3,24]],"date-time":"2011-03-24T00:00:00Z","timestamp":1300924800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0018204","type":"journal-article","created":{"date-parts":[[2011,3,24]],"date-time":"2011-03-24T21:02:02Z","timestamp":1301000522000},"page":"e18204","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["HIV Quasispecies Dynamics during Pro-Active Treatment Switching: Impact on Multi-Drug Resistance and Resistance Archiving in Latent Reservoirs"],"prefix":"10.1371","volume":"6","author":[{"given":"Max","family":"von Kleist","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Menz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"Stocker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keikawus","family":"Arasteh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof","family":"Sch\u00fctte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilhelm","family":"Huisinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,3,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.","volume":"278","author":"D Finzi","year":"1997","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/8394","article-title":"Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.","volume":"5","author":"D Finzi","year":"1999","journal-title":"Nat Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","article-title":"Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.","volume":"278","author":"JK Wong","year":"1997","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm.2109","article-title":"HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs.","volume":"16","author":"CC Carter","year":"2010","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/nm1295-1284","article-title":"In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.","volume":"1","author":"TW Chun","year":"1995","journal-title":"Nat Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","article-title":"Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.","volume":"94","author":"TW Chun","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/387183a0","article-title":"Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.","volume":"387","author":"TW Chun","year":"1997","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev.immunol.18.1.665","article-title":"Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.","volume":"18","author":"T Pierson","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jac\/dkh292","article-title":"A long-term latent reservoir for HIV-1: discovery and clinical implications.","volume":"54","author":"JD Siliciano","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/00002030-200405210-00008","article-title":"The lymphocyte HIV reservoir in patients on long-term HAART is a memory of virus evolution.","volume":"18","author":"O Lambotte","year":"2004","journal-title":"AIDS"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1468-1293.2009.00816.x","article-title":"History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change.","volume":"11","author":"J Reekie","year":"2010","journal-title":"HIV Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/373123a0","article-title":"Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.","volume":"373","author":"DD Ho","year":"1995","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1001\/jama.293.22.2776","article-title":"Update on the treatment of tuberculosis and latent tuberculosis infection.","volume":"293","author":"HM Blumberg","year":"2005","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ehj.2003.11.008","article-title":"Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the european society of cardiology.","volume":"25","author":"D Horstkotte","year":"2004","journal-title":"Eur Heart J"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s15010-002-3079-9","article-title":"Management of infection associated with prosthetic joints.","volume":"31","author":"W Zimmerli","year":"2003","journal-title":"Infection"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1371\/journal.pcbi.0030133","article-title":"Optimal timing and duration of induction therapy for HIV-1 infection.","volume":"3","author":"ME Curlin","year":"2007","journal-title":"PLoS Comput Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11904-004-0013-z","article-title":"Drug interactions with antiretrovirals.","volume":"1","author":"LM Catanzaro","year":"2004","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nrd1151","article-title":"Toxicity of antiretroviral therapy and implications for drug development.","volume":"2","author":"A Carr","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/135965359800300302","article-title":"Management of antiretroviral therapy for HIV infection: modelling when to change therapy.","volume":"3","author":"RM D'Amato","year":"1998","journal-title":"Antivir Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-139-2-200307150-00007","article-title":"Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial.","volume":"139","author":"J Martinez-Picado","year":"2003","journal-title":"Ann Intern Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/135965350400900602","article-title":"Alternation of antiretroviral drug regimens for HIV infection. efficacy, safety and tolerability at week 96 of the Swatch study.","volume":"9","author":"E Negredo","year":"2004","journal-title":"Antivir Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1258\/095646207782193821","article-title":"Successive switching of antiretroviral therapy is associated with high psychological and physical burden.","volume":"18","author":"L Sherr","year":"2007","journal-title":"Int J STD AIDS"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e1000720","DOI":"10.1371\/journal.pcbi.1000720","article-title":"Drug-class specific impact of antivirals on the reproductive capacity of HIV.","volume":"6","author":"M von Kleist","year":"2010","journal-title":"PLoS Comput Biol"},{"key":"ref24","first-page":"1","article-title":"Panel on Antiretroviral Guidelines for Adults and Adolescents.","journal-title":"Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1051\/proc:2005001","article-title":"Exact simulation of hybrid stochastic and deterministic models for biochemical systems.","volume":"14","author":"A Alfonsi","year":"2005","journal-title":"ESAIM Proc"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/jac\/dkp132","article-title":"Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice.","volume":"64","author":"M Fabbiani","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMra025195","article-title":"HIV drug resistance.","volume":"350","author":"F Clavel","year":"2004","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/2047-783X-14-S3-47","article-title":"HIV resistance to raltegravir.","volume":"14","author":"F Clavel","year":"2009","journal-title":"Eur J Med Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1056\/NEJMoa074609","article-title":"Class-sparing regimens for initial treatment of HIV-1 infection.","volume":"358","author":"SA Riddler","year":"2008","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1086\/317615","article-title":"Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection.","volume":"182","author":"JN Blankson","year":"2000","journal-title":"J Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1386-6532(03)00083-0","article-title":"Enumeration of latently infected CD4+ T cells from HIV-1-infected patients using an HIV-1 antigen ELISPOT assay.","volume":"29","author":"JM Fondere","year":"2004","journal-title":"J Clin Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/135965350000500110","article-title":"Principles of HIV resistance testing and overview of assay performance characteristics.","volume":"5","author":"DD Richman","year":"2000","journal-title":"Antivir Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e1000074","DOI":"10.1371\/journal.pcbi.1000074","article-title":"Viral population estimation using pyrosequencing.","volume":"4","author":"N Eriksson","year":"2008","journal-title":"PLoS Comput Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1097\/00002030-199912030-00006","article-title":"Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy.","volume":"13","author":"M Nijhuis","year":"1999","journal-title":"AIDS"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e1000305","DOI":"10.1371\/journal.pcbi.1000305","article-title":"Timing the emergence of resistance to anti-HIV drugs with large genetic barriers.","volume":"5","author":"P Arora","year":"2009","journal-title":"PLoS Comput Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1128\/JVI.77.8.5037-5038.2003","article-title":"A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo.","volume":"77","author":"M Markowitz","year":"2003","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","article-title":"HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.","volume":"271","author":"AS Perelson","year":"1996","journal-title":"Science"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/387188a0","article-title":"Decay characteristics of HIV-1-infected compartments during combination therapy.","volume":"387","author":"AS Perelson","year":"1997","journal-title":"Nature"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e9263","DOI":"10.1371\/journal.pone.0009263","article-title":"HIV drug resistance surveillance using pooled pyrosequencing.","volume":"5","author":"H Ji","year":"2010","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/QAD.0b013e32832b4399","article-title":"Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencing.","volume":"23","author":"J Archer","year":"2009","journal-title":"AIDS"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00002030-199805000-00006","article-title":"The frequency of resistant mutant virus before antiviral therapy.","volume":"12","author":"RM Ribeiro","year":"1998","journal-title":"AIDS"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1128\/JVI.69.8.5087-5094.1995","article-title":"Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.","volume":"69","author":"LM Mansky","year":"1995","journal-title":"J Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.virusres.2007.12.021","article-title":"HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.","volume":"134","author":"J Martinez-Picado","year":"2008","journal-title":"Virus Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1126\/science.1180556","article-title":"Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco.","volume":"327","author":"RJ Smith","year":"2010","journal-title":"Science"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/01.aids.0000199820.47703.a0","article-title":"HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time.","volume":"20","author":"J Ghosn","year":"2006","journal-title":"AIDS"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/00126334-200202011-00002","article-title":"Addressing the challenges of adherence.","volume":"29","author":"JA Bartlett","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1097\/QAD.0b013e3282f12377","article-title":"Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase.","volume":"21","author":"JM Murray","year":"2007","journal-title":"AIDS"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.qai.0000233308.82860.2f","article-title":"Antiviral activity, pharmacokinetics, and dose response of the HIV-1 integrase inhibitor gs-9137 (jtk-303) in treatment-naive and treatment-experienced patients.","volume":"43","author":"E DeJesus","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1073\/pnas.0711372105","article-title":"Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle.","volume":"105","author":"AR Sedaghat","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0140-6736(09)60918-1","article-title":"Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.","volume":"374","author":"JL Lennox","year":"2009","journal-title":"Lancet"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/QAI.0b013e3181da1287","article-title":"Raltegravir versus efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses.","volume":"55","author":"JL Lennox","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/S0140-6736(99)02035-8","article-title":"Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis.","volume":"354","author":"B Ramratnam","year":"1999","journal-title":"Lancet"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.","volume":"363","author":"RM Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jama.2010.1278","article-title":"Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial.","volume":"304","author":"A Coovadia","year":"2010","journal-title":"JAMA"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2005.06.006","article-title":"Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 tat fluctuations drive phenotypic diversity.","volume":"122","author":"LS Weinberger","year":"2005","journal-title":"Cell"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1371\/journal.ppat.0020068","article-title":"Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells.","volume":"2","author":"KG Lassen","year":"2006","journal-title":"PLoS Pathog"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJM199905273402101","article-title":"Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.","volume":"340","author":"L Zhang","year":"1999","journal-title":"N Engl J Med"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/518250","article-title":"Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.","volume":"195","author":"TW Chun","year":"2007","journal-title":"J Infect Dis"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.","volume":"9","author":"JD Siliciano","year":"2003","journal-title":"Nat Med"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/71577","article-title":"The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.","volume":"6","author":"B Ramratnam","year":"2000","journal-title":"Nat Med"},{"key":"ref61","author":"J Coffin","year":"2006"},{"key":"ref62","first-page":"447","article-title":"Numerical differentiation formulas for stiff systems of ordinary differential equations.","volume":"32","author":"R Klopfenstein","year":"1971","journal-title":"RCA Review"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1137\/S1064827594276424","article-title":"The Matlab ODE Suite.","volume":"18","author":"L Shampine","year":"1997","journal-title":"SIAM Journal on Scientific Computing"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/373117a0","article-title":"Viral dynamics in human immunodeficiency virus type 1 infection.","volume":"373","author":"X Wei","year":"1995","journal-title":"Nature"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/135965350901400212","article-title":"Constraints on the dominant mechanism for HIV viral dynamics in patients on raltegravir.","volume":"14","author":"AR Sedaghat","year":"2009","journal-title":"Antivir Ther"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/bulm.2001.0266","article-title":"HIV-1 infection and low steady state viral loads.","volume":"64","author":"DS Callaway","year":"2002","journal-title":"Bull Math Biol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1086\/525283","article-title":"Dynamics of total, linear nonintegrated, and integrated HIV-1DNA in vivo and in vitro.","volume":"197","author":"KK Koelsch","year":"2008","journal-title":"J Infect Dis"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1128\/JVI.79.4.2199-2210.2005","article-title":"Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells.","volume":"79","author":"Y Zhou","year":"2005","journal-title":"J Virol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"8518","DOI":"10.1128\/JVI.76.17.8518-8513.2002","article-title":"Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection.","volume":"76","author":"TC Pierson","year":"2002","journal-title":"J Virol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0018204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T11:47:54Z","timestamp":1712317674000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0018204"}},"subtitle":[],"editor":[{"given":"Art","family":"Poon","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,3,24]]},"references-count":69,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,3,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0018204","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,24]]}}}